The devices segment, which includes MRI-ultrasound fusion systems ... of healthcare providers with its use. Fusion biopsy is primarily used for prostate cancer diagnosis, although it also has ...

Fusion biopsy market size was valued at USD 829.1 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2034. The market's rapid expansion is driven by ...

As these elderly individuals grows globally, the incidence of prostate cancer is also expected to increase leading to increased demand for advanced diagnostic technologies such as fusion biopsy.

The global fusion biopsy market is valued at an estimated USD 0.65 billion in 2024 and is projected to reach USD 0.91 billion by 2029, at a CAGR of 7.1% during the forecast period. The elderly ...

Control biopsy sampling in real time and record 3D mapping for further personalized patient management. Suitable for primary session biopsy with or without MRI. Improve the detection rate by a ...

MRI scanning and biopsy could reduce delays in the correct treatment for bladder cancer by more than six weeks. ScienceDaily . Retrieved February 5, 2025 from www.sciencedaily.com / releases ...

Investigations: Physical examination, laboratory evaluation,endorectal MRI of the prostate, cystoscopy and biopsy. Diagnosis: Poorly differentiated adenocarcinoma of theprostate, with invasion of ...

Fusion Biopsy market is estimated to be valued at USD 791.1 Mn in 2025 and is expected to reach USD 1,418.2 Mn by 2032 exhibiting a CAGR of 8.7% from 2025-2032. Rising prostate cancer cases drive ...